Skip to main content
. Author manuscript; available in PMC: 2009 Feb 25.
Published in final edited form as: Ann Neurol. 2008 Jul;64(1):97–108. doi: 10.1002/ana.21430

Table 2.

Recommended Initial Screening Tests for Evaluation of a Rapidly Progressive Dementia

Category Required Tests Sometimes Helpful
Blood tests CBC Cancer screen
Chemistry panel (including calcium, magnesium, phosphorus) Blood smear
LFTs Hypercoagulability testing
RPR Copper and ceruloplasmin
Rheumatological screen (ESR, ANA, and CRP) Methylmalonic acid levels
Additional rheumatological tests
Thyroid function Coagulation profile
Anti-thyroglobulin and anti-thyroperoxidase antibodies
Vitamin B12
Homocysteine
HIV
Lyme
Paraneoplastic/autoimmune antibodies
Urine Urine analysis Urine culture
Copper (24 hours, if Wilson’s disease suspected)
Heavy metal screen (24 hours)
CSF Cell count and differential Cryptococcal antigen
Protein Viral PCRs and cultures
Glucose Bacterial, fungal, AFB stains, and cultures
IgG index Cytology
Oligoclonal bands Whipple’s PCR
VDRL 14-3-3 test
Total and phosphorylated tau
Imaging Brain MRI (including FLAIR and DWI) with and without contrast CT head
CT chest, abdomen, and pelvis with and without contrast
Brain angiogram
Mammogram
Body PET scan
MRS
Carotid ultrasound
Echocardiogram
Other tests EEG EMG/NCS
Brain biopsy (especially if procedures listed earlier are nondiagnostic)

CBC =complete blood cell count; LFT =liver function test; RPR =rapid plasmin reagin (test); ESR =erythrocyte sedimentation rate; ANA =antinuclear antibody; CRP =C-reactive protein; IgG =immunoglobulin G; HIV =human immunodeficiency virus; CSF =cerebrospinal fluid; VDRL =Venereal Disease Research Laboratory (test); PCR =polymerase chain reaction; AFB =acid-fast bacilli; MRI =magnetic resonance imaging; FLAIR =fluid-attenuated inversion recovery; DWI =diffusion-weighted imaging; CT =computed tomography; PET =positron emission tomography; MRS =magnetic resonance spectroscopy; EEG =electroencephalogram; EMG =electromyogram; NCS =nerve conduction study.